Mayo Clinic Platform

About

Portfolio · 3

Quai MD

AI-based Best-practices Platform

1 round $3.0M committed Latest: 2024-07

Bionaut Labs

Precision-targeted Medicine Modality for CNS Disorders

1 round $6.0M committed Latest: 2024-02

AccuLine

Preventing the next Heart Attack

1 round $3.5M committed

Investment activity

Q&A

What is Mayo Clinic Platform's primary investment focus?

Mayo Clinic Platform primarily focuses on the Health Tech & Life Sciences sector, with all three of its known portfolio companies operating in this area.

Can you name some of Mayo Clinic Platform's portfolio companies?

Mayo Clinic Platform's portfolio includes AccuLine, which focuses on preventing heart attacks, and Bionaut Labs, which develops precision-targeted medicine for CNS disorders.

What is the typical investment range for Mayo Clinic Platform?

Mayo Clinic Platform typically invests between $3M and $6M per round.

What stages of funding does Mayo Clinic Platform participate in?

Mayo Clinic Platform has participated in Pre-Seed, Seed, and B Round funding stages.

Has Mayo Clinic Platform made any recent investments?

Yes, Mayo Clinic Platform made one investment in February 2024 and another in July 2024.

What is AccuLine, one of Mayo Clinic Platform's portfolio companies?

AccuLine is a B2B company founded in 2022 that aims to prevent heart attacks. Mayo Clinic Platform participated in its Pre-Seed round, which raised $6.25M.

What is Bionaut Labs, a company in Mayo Clinic Platform's portfolio?

Bionaut Labs, founded in 2016, is a B2B company developing a precision-targeted medicine modality for CNS disorders. Mayo Clinic Platform participated in its B Round, which raised $69.2M.

What kind of company is Quai MD?

Quai MD, founded in 2020, is a B2B and B2B2C company that offers an AI-based best-practices platform. Mayo Clinic Platform participated in its Pre-Seed round, which raised $6.3M.